Physician profile
Damon Cobb
NPI 1851435598
$586.45
in general payments reported to CMS, 2019-2025
12 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $94.23 · 2022: $36.78 · 2023: $20.66 · 2024: $9.77 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $149.23 | 2025 | Annovera, Nextstellis |
| Allergan, INC. | $89.56 | 2019-2020 | |
| Hologic Sales and Service, LLC | $72.60 | 2020-2025 | Aptima |
| Abbvie INC. | $65.35 | 2019-2022 | |
| Roche Diagnostics Corporation | $45.54 | 2019 | |
| Aspira Women'S Health INC | $38.87 | 2022-2024 | Ova1 |
| Alnylam Pharmaceuticals INC. | $30.64 | 2025 | Amvuttra |
| Therapeuticsmd, INC. | $22.87 | 2019 | |
| Duchesnay USA Incorporated | $21.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.44 | 2019 | |
| Exeltis, USA INC. | $16.93 | 2019 | |
| Sumitomo Pharma America, INC. | $12.85 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.